Vericel (VCEL) Preferred Shares (2013 - 2016)
Vericel's (VCEL) quarterly Preferred Shares came in at $38.4 million in Q4 2016, up 1118.7% year-on-year from $3.2 million in Q1 2016, and little changed quarter-over-quarter from $38.4 million in Q3 2016.
Vericel (VCEL) Preferred Shares (2013 - 2016) Analysis & Trends
Vericel has disclosed Preferred Shares across 4 years of filings, most recently posting $38.4 million for Q4 2016.
- Preferred Shares for Q4 2016 came in at $38.4 million, up 1118.7% year-over-year; the trailing twelve-month figure through Dec 2016 was $38.4 million (up 1118.7% YoY), and the FY2016 annual result was $38.4 million, up 1118.7% from the prior year.
- Preferred Shares came in at $38.4 million for Q4 2016 at Vericel, roughly flat from $38.4 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $38.4 million in Q3 2013 to a low of $3.2 million in Q4 2015.
- The 4-year median for Preferred Shares is $38.4 million (2013), against an average of $35.9 million.
- Across the five-year window, Preferred Shares slumped 91.79% in 2015 and surged 1118.7% in 2016, its largest moves.
- Vericel's Preferred Shares stood at $38.4 million in 2013, then changed by 0.0% to $38.4 million in 2014, then plunged by 91.79% to $3.2 million in 2015, then soared by 1118.7% to $38.4 million in 2016.
- The last three Preferred Shares figures came in at $38.4 million (Q4 2016), $38.4 million (Q3 2016), and $38.4 million (Q2 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 38.39 Mn |
| Sep 30, 2016 | 38.39 Mn |
| Jun 30, 2016 | 38.39 Mn |
| Mar 31, 2016 | 38.39 Mn |
| Dec 31, 2015 | 3.15 Mn |
| Sep 30, 2015 | 38.39 Mn |
| Jun 30, 2015 | 38.39 Mn |
| Mar 31, 2015 | 38.39 Mn |
| Dec 31, 2014 | 38.39 Mn |
| Sep 30, 2014 | 38.39 Mn |
| Jun 30, 2014 | 38.39 Mn |
| Mar 31, 2014 | 38.39 Mn |
| Dec 31, 2013 | 38.39 Mn |
| Sep 30, 2013 | 38.39 Mn |